Stocksigma LogoStocksigma Logo

Amerise Biosciences Reports Q2 FY27 Net Loss Amid Zero Operating Revenue

Amerise Biosciences reported zero revenue from operations for the quarter ended 30th Sep'26, down from total income of Rs 6.75 lakh in Q2 FY26

Amerise Biosciences Reports Q2 FY27 Net Loss Amid Zero Operating Revenue

Amerise Biosciences Ltd 路 Financial Result 路 30 Oct 2026, 10:29 pm

Amerise Biosciences Reports Q2 FY27 Net Loss Amid Zero Operating Revenue Amerise Biosciences reported zero revenue from operations for the quarter ended 30th Sep'26, down from total income of Rs 6.75 lakh in Q2 FY26. Total expenses stood at Rs 5.76 lakh versus Rs 10.98 lakh YoY and Rs 8.14 lakh QoQ. Consequently, net loss widened YoY to Rs 5.76 lakh from Rs 4.23 lakh in Q2 FY26, though narrowing QoQ from Rs 8.14 lakh. EPS stood at negative Rs 0.01. For H1 FY27, net loss widened to Rs 13.91 lakh compared to Rs 5.04 lakh YoY.

Original exchange filing (PDF)

More announcements from Amerise Biosciences Ltd

All Amerise Biosciences Ltd announcements